Publication at Faculty of Medicine in Hradec Králové |
2021
Abstract
Lurasidone is a serotonin and dopamine receptor antagonist, one of the most recently available antipsychotics in the Czech Republic. It has a minimal effect on physical and metabolic parameters while a significant effectiveness on the symptoms of psychosis is maintained.
This is evidenced by the case report below, which describes a good response to lurasidone in a patient with paranoid schizophrenia and resistence to treatment, including electroconvulsive therapy.